Human CHN1 mutations hyperactivate α2-chimaerin and cause Duane's retraction syndrome

152Citations
Citations of this article
81Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Duane's retraction syndrome (DRS) is a complex congenital eye movement disorder caused by aberrant innervation of the extraocular muscles by axons of brainstem motor neurons. Studying families with a variant form of the disorder (DURS2-DRS), we have identified causative heterozygous missense mutations in CHN1, a gene on chromosome 2q31 that encodes α2-chimaerin, a Rac guanosine triphosphatase-activating protein (RacGAP) signaling protein previously implicated in the pathfinding of corticospinal axons in mice. We found that these are gain-of-function mutations that increase α2-chimaerin RacGAP activity in vitro. Several of the mutations appeared to enhance α2-chimaerin translocation to the cell membrane or enhance its ability to self-associate. Expression of mutant α2-chimaerin constructs in chick embryos resulted in failure of oculomotor axons to innervate their target extraocular muscles. We conclude that α2-chimaerin has a critical developmental function in ocular motor axon pathfinding.

Cite

CITATION STYLE

APA

Miyake, N., Chilton, J., Psatha, M., Cheng, L., Andrews, C., Chan, W. M., … Engle, E. C. (2008). Human CHN1 mutations hyperactivate α2-chimaerin and cause Duane’s retraction syndrome. Science, 321(5890), 839–843. https://doi.org/10.1126/science.1156121

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free